Neovasc Inc
F:G5Z3
Neovasc Inc
F:G5Z3
Price:
0.325
EUR
-1.22%
Market Closed
Market Cap:
€879.5k
Relative Value
There is not enough data to reliably calculate the relative value of G5Z3.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
G5Z3
Relative Value
Base Case
Not Available
Multiples Across Competitors
G5Z3 Competitors Multiples
Neovasc Inc Competitors
Neovasc Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Neovasc Inc
F:G5Z3
|
110.5m EUR | 21.2 | -2 | -2.1 | -2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.1B USD | 4.2 | 28.5 | 16.3 | 22.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.4B USD | 16.9 | 59.7 | 45.3 | 55.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
130B USD | 5.2 | 40 | 20.4 | 24.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.5B USD | 3.1 | 24.2 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.6B USD | 5.2 | 35.8 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.2B EUR | 1.8 | 19.9 | 11.2 | 15.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD | 7.9 | 44.6 | 24.6 | 26.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.2B USD | 10.7 | 43.6 | 30.9 | 34.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.6B USD | 2 | 25.4 | 10 | 16.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.1B USD | 6.1 | 22.3 | 15.7 | 17.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
